首页> 外文期刊>Inorganica Chimica Acta >Ruthenium(III) complexes with monodentate 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one: Structural characterization, interaction with DNA and proteins
【24h】

Ruthenium(III) complexes with monodentate 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one: Structural characterization, interaction with DNA and proteins

机译:具有单齿5-甲基-1,2,4-三唑并[1,5-a]嘧啶-7(4H)的钌(III)配合物:结构表征,与DNA和蛋白质的相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

X-ray structures of two Ru(III) complexes of the "Keppler-type", [(CH3)(2)NH2]trans-[RuCl4(HmtpO)(2)] (1a) and [H(2)mtpO]trans-[RuCl4(HmtpO)(2)]center dot 3H(2)O (1b), have been determined. The structures of both compounds established two monodentate heterocycle ligands (HmtpO) via N3 in axial positions and four equatorial chloride ions. The complexes differ only in the counter ion, which is a protonated dimethylamine [(CH3)(2)NH2](+) for (1a) and a protonated [H(2)mtpO](+) for (1b). Additionally, (1a) was characterized by EPR spectroscopy, and the effective magnetic moment measurement supports the paramagnetic character, corresponding to the expected 4d(5) (S = 1/2) electron configuration for a Ru(III) core. CD studies on hydrophilic (1a) (logP = -1.28) suggested Ru(III) mechanisms of biological action that involve activation by reduction (with E-red = -0.053 V versus NHE) and selective delivery by apotransferrin. Furthermore, it is suggested that the described (1a)-BSA adducts might form in vivo and might be relevant for the biological properties of this complex, and thus adducts may be tested as specific carriers of the ruthenium complex to cancer cells. (C) 2016 Elsevier B.V. All rights reserved.
机译:两种“开普勒型” Ru(III)配合物[[CH3)(2)NH2] trans- [RuCl4(HmtpO)(2)](1a)和[H(2)mtpO]的X射线结构已确定反-[RuCl4(HmtpO)(2)]中心点3H(2)O(1b)。两种化合物的结构通过轴向位置的N3和四个赤道氯离子建立了两个单齿杂环配体(HmtpO)。络合物仅在抗衡离子上有所不同,抗衡离子是(1a)的质子化二甲胺[(CH3)(2)NH2](+)和(1b)的质子化的[H(2)mtpO](+)。此外,(1a)用EPR光谱表征,有效磁矩测量支持顺磁特性,对应于Ru(III)磁芯的预期4d(5)(S = 1/2)电子构型。 CD对亲水性(1a)(logP = -1.28)的研究表明,Ru(III)的生物作用机制涉及还原(通过E-red = -0.053 V相对于NHE)的活化和载脂蛋白的选择性传递。此外,建议所述的(1a)-BSA加合物可能在体内形成并且可能与该复合物的生物学性质有关,因此可以将加合物作为钌复合物对癌细胞的特异性载体进行测试。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号